Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #180425 on Cytodyn Inc (CYDY)
Chuckles759
08/24/21 11:08 PM
#180470 RE: JPG77 #180425
Last Monday (2/8), Anvisa approved the start of a clinical study to assess the safety and efficacy of the drug leronlimab in the treatment of moderately ill patients with pneumonia caused by Covid-19. This is one of more than 100 clinical studies of Covid-19 drugs and vaccines authorized by the Agency. Since the beginning of the pandemic , Anvisa has been working so that the Brazilian population has access to the greatest possible number of vaccines and medicines against the infection caused by the new coronavirus . The agility that this commitment requires , however, cannot compromise the quality , efficacy and, especially, the guarantee of safety of the products in use in Brazil.